Pharmacokinetic and pharmacodynamic studies of tienilic acid in healthy volunteers. 1982

A L Kerremans, and F W Gribnau, and Y Tan, and C A van Ginneken

A simple and reliable HPLC method for the determination of tienilic acid ((TA) Selacryn, Selcryn, Diflurex, Ticrynafen) and its alcoholic metabolite in plasma and urine has been developed. In 8 healthy adult volunteers the plasma and urinary levels of tienilic acid and its alcoholic metabolite, and plasma and urinary levels of sodium, creatinine and uric acid were measured after oral administration of tienilic acid 250 mg. The pharmacokinetic parameters found differed only slightly from those reported in the literature, as there was faster absorption and a shorter half-life. TA is probably excreted by a saturable renal tubular transport mechanism. The pharmacodynamic effects of tienilic acid developed quickly, the uricosuric effect being very impressive and the natriuretic effect moderate. These effects disappeared in about 8 h. An inverse relationship was found between the starting plasma uric acid level in an individual and the maximal uric acid clearance - the higher the plasma uric acid level, the lower was the maximum effect. Plasma tienilic acid level and natriuretic effect were correlative within individuals and intra-individually (p less than 0.05). Urinary tienilic acid level and natriuretic effect were correlated, too (p less than 0.05 to p less than 0.001), but only intraindividually. No correlation between drug level and uricosuric effect was found.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006016 Glycolates Derivatives of ACETIC ACID which contain an hydroxy group attached to the methyl carbon. 2-Hydroxyacetates,Glycolate Ethers,Hydroxyacetate Ethers,Hydroxyacetates,Hydroxyacetic Acids,2 Hydroxyacetates,Acids, Hydroxyacetic,Ethers, Glycolate,Ethers, Hydroxyacetate
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23

Related Publications

A L Kerremans, and F W Gribnau, and Y Tan, and C A van Ginneken
July 2003, Archives of pharmacal research,
A L Kerremans, and F W Gribnau, and Y Tan, and C A van Ginneken
March 2001, International journal of clinical pharmacology and therapeutics,
A L Kerremans, and F W Gribnau, and Y Tan, and C A van Ginneken
September 1990, International journal of clinical pharmacology, therapy, and toxicology,
A L Kerremans, and F W Gribnau, and Y Tan, and C A van Ginneken
August 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
A L Kerremans, and F W Gribnau, and Y Tan, and C A van Ginneken
July 2016, Journal of clinical pharmacology,
A L Kerremans, and F W Gribnau, and Y Tan, and C A van Ginneken
October 2002, Clinical pharmacology and therapeutics,
A L Kerremans, and F W Gribnau, and Y Tan, and C A van Ginneken
January 2002, Arzneimittel-Forschung,
A L Kerremans, and F W Gribnau, and Y Tan, and C A van Ginneken
January 2003, Clinical pharmacokinetics,
A L Kerremans, and F W Gribnau, and Y Tan, and C A van Ginneken
October 1999, British journal of clinical pharmacology,
A L Kerremans, and F W Gribnau, and Y Tan, and C A van Ginneken
January 2002, Clinical pharmacokinetics,
Copied contents to your clipboard!